Sientra share weakness poised to flip after stable quarter - analyst

Project Sage Oldco

09/08/2019 14:27

** Medical aesthetics company's shares  SIEN.O  up 16% at
$5.79 premarket     
    ** Co on Thursday posted Q2 sales of 20.5 mln vs. Est. $19
mln - Refinitiv IBES  urn:newsml:reuters.com:*:nGNX2mzHWh
    ** Co says has gained market share after rival Allergan Plc
 AGN.N  recalled its Biocell textured breast implants across
markets after FDA cited concerns over a rare form of cancer
    ** We believe pessimism and share weakness are poised to
flip after another stable quarter, Craig-Hallum analyst
Alexander Nowak says 
    ** The beat was driven by strength across its primary
business segments, with 19% growth in breast products and 15%
growth in sales of underarm sweat treatment miraDry, William
Blair analyst Margaret Kaczor says
    ** Up to Thursday's close, stock had fallen 60.7% YTD

 (Reporting by Tamara Mathias in Bengaluru)
 ((Tamara.Mathias@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 1208;))